Artelo Biosciences Announces Proposed Underwritten Public Offering
1. Artelo Biosciences announced a public offering of common stock and/or warrants. 2. The offering is subject to market conditions, affecting its completion timeline. 3. R.F. Lafferty & Co. is the sole book-running manager for the offering. 4. The company focuses on therapies for cancer, pain, and neurological conditions. 5. Artelo is also investing in Solana as part of its treasury strategy.